Cigna Group (NYSE:CI) Upgraded at Wall Street Zen

29 Sep 2026, 05:06 by Michael Walen · The Markets Daily

Wall Street Zen upgraded shares of Cigna Group (NYSE:CI – Free Report) from a hold rating to a buy rating in a research note published on Saturday morning,Wall Street Zen reports.

CI has been the topic of several other reports. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Wells Fargo & Company increased their price objective on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Evercore initiated coverage on Cigna Group in a research note on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price objective on the stock. Guggenheim upped their target price on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Finally, Barclays increased their price target on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $337.10.

Check Out Our Latest Analysis on CI

Cigna Group Stock Performance

CI stock opened at $271.66 on Friday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $71.78 billion, a price-to-earnings ratio of 11.24, a P/E/G ratio of 0.93 and a beta of 0.31. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The firm has a 50 day moving average of $280.08 and a two-hundred day moving average of $280.41.

Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the prior year, the business posted $7.20 EPS. Cigna Group’s quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th were issued a $1.56 dividend. The ex-dividend date of this dividend was Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is 25.82%.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the firm’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 22,730 shares of company stock worth $6,293,359. Company insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. grew its holdings in shares of Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after purchasing an additional 840,098 shares in the last quarter. GQG Partners LLC acquired a new position in shares of Cigna Group in the second quarter valued at $1,628,918,000. Norges Bank bought a new position in Cigna Group in the fourth quarter worth $1,019,790,000. Bank of America Corp DE boosted its stake in Cigna Group by 8.8% during the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after buying an additional 256,677 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its stake in Cigna Group by 9.8% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,958,656 shares of the health services provider’s stock worth $814,311,000 after buying an additional 263,036 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

About Cigna Group

(Get Free Report)

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.